Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PSTI

Pluristem Therapeutics (PSTI) Stock Price, News & Analysis

Pluristem Therapeutics logo

About Pluristem Therapeutics Stock (NASDAQ:PSTI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.00
$1.58
52-Week Range
N/A
Volume
2,128 shs
Average Volume
715,259 shs
Market Capitalization
$32.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PSTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pluristem Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PSTI Stock News Headlines

NBRVF Nabriva Therapeutics plc
Pluri CEO Issues Shareholder Update
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
See More Headlines

PSTI Stock Analysis - Frequently Asked Questions

Pluristem Therapeutics Inc. (NASDAQ:PSTI) released its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.05.

Shares of Pluristem Therapeutics reverse split on the morning of Thursday, July 25th 2019.The 1-10 reverse split was announced on Wednesday, July 24th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pluristem Therapeutics investors own include NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Teva Pharmaceutical Industries (TEVA), Meta Platforms (META), Gilead Sciences (GILD), Novavax (NVAX) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/08/2021
Today
7/12/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PSTI
CIK
1158780
Employees
153
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($1.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.87 million
Net Margins
N/A
Pretax Margin
-20,024.79%
Return on Equity
-100.63%
Return on Assets
-55.46%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
8.22
Quick Ratio
8.22

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
32,348,000
Free Float
30,601,000
Market Cap
$32.35 million
Optionable
Optionable
Beta
1.91

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:PSTI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners